NEJM corrects its study on rofecoxib

被引：0

|

作者：

Mayor, S

机构：

来源：

BRITISH MEDICAL JOURNAL | 2006年 / 333卷 / 7557期

关键词：

D O I：

10.1136/bmj.333.7557.12-b

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：12 / 12

页数：1

相关论文

共 50 条

[1] NEJM stands by its criticism of Vioxx study
Tanne, JH
[J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7540): : 505 - 505
[2] NEJM reckons with its past
Brainard, Jeffrey
[J]. SCIENCE, 2023, 382 (6675) : 1095 - 1095
[3] Bioequivalence study of rofecoxib tablets
Koytchev, R
Ozalp, Y
Erenmemisoglu, A
van der Meer, MJ
Alpan, RS
[J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (9A): : 624 - 628
[4] Introducing NEJM Knowledge plus and Its Adaptive Personalized Learning
McMahon, Graham T.
Drazen, Jeffrey M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (17): : 1648 - 1649
[5] AMONG LEADING MEDICAL JOURNALS, ITS NEJM THAT SETS THE CITATION PACE
不详
[J]. SCIENTIST, 1988, 2 (22): : 15 - 15
[6] Synthesis Research Progress of Rofecoxib and Its Derivatives
Liu, Gaizhi
Han, Deen
Wang, Peng
Liu, Hongmin
[J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2013, 33 (08) : 1674 - 1685
[7] Conflict of interest -: NEJM admits breaking its own tough rules
Holden, C
[J]. SCIENCE, 2000, 287 (5458) : 1573 - 1573
[8] A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
Kulkarni, Madhur
Nagarsenker, Mangal
[J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (04) : 466 - 471
[9] FDA warns Merck over its promotion of rofecoxib
Josefson, D
[J]. BRITISH MEDICAL JOURNAL, 2001, 323 (7316): : 767 - 767
[10] Adoption of celecoxib and rofecoxib: a nationwide database study
Helin-Salmivaara, A
Huupponen, R
Virtanen, A
Klaukka, T
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (02) : 145 - 152

← 1 2 3 4 5 →